Trial Profile
Pilot study of incretin analogs as new therapeutics for Friedreich's Ataxia.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2014
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Liraglutide (Primary)
- Indications Friedreich's ataxia
- Focus Adverse reactions; Pharmacodynamics
- 13 Nov 2014 New trial record